Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...

Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In ...

In light of increasing incidents and data breaches across the industry, healthcare organizations are responding by beefing up their proactive cyber defenses to address privacy and security ...

The litigation tying up the Federal Trade Commission’s new rule prohibiting for-profit companies from requiring noncompete clauses gives everyone in healthcare time to consider the unique needs ...

Medical coding is an unavoidable part of healthcare delivery. Coding is essential for accurate documentation, billing and reimbursement in healthcare — yet many providers still rely on manual ...

If four full 737s were crashing daily resulting in total loss of life, there would be a public outcry and immediate governmental intervention. Yet, we lose an equivalent number of people daily ...

The MedCity Moves Podcast is back with another episode. During the episode, Senior Reporter Katie Adams discussed some of the executive hires and exits occurring in the healthcare world over the ...

More and more providers are expanding their use of AI-based documentation tools after witnessing how much time these solutions can save clinicians. On Wednesday, Alpine Physician Partners ...

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...

There has been a huge demand for healthcare AI this year — with three-quarters of the country’s providers and payers having increased their IT spending over the past year. This enthusiasm for ...

Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...